Arcturus Therapeutics
UEI: E3MFDBN4L3J9
• CAGE: 6X1L5
Overview
Awardee Type
Parent
Company Description
Arcturus Therapeutics is a global late-stage clinical messenger RNA medicines and vaccines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines.
Name
Arcturus Therapeutics
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
Sept. 1, 2022
Calculating
Federal contract recipient
ARCTURUS THERAPEUTICS, INC.
dba ARCTURUS THERAPEUTICS INC
(UEI E3MFDBN4L3J9, CAGE 6X1L5)
is headquartered in San Diego CA.
Its primary registered NAICS is 325414 Biological Product (except Diagnostic) Manufacturing.
The corporation
was founded in February 2013 and
federally registered in
May 2013.
Federal Award Analysis
Arcturus Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ARCTURUS THERAPEUTICS, INC.
DBA
ARCTURUS THERAPEUTICS INC
UEI
E3MFDBN4L3J9
CAGE Code
6X1L5
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 6, 2013
Initial Registration
May 2, 2013
Last Registration
Dec. 12, 2024
Registration Activation
Dec. 12, 2024
Registration Expiration
Dec. 10, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Accepts Credit Cards
No